ArticleLiver cancer2025

Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries.

Choong-Kun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.